SG11201400073SA - Peptide nanoparticles and uses thereof - Google Patents

Peptide nanoparticles and uses thereof

Info

Publication number: SG11201400073SA
Authority: SG; Singapore
Prior art keywords: peptide nanoparticles; nanoparticles; peptide
Prior art date: 2011-08-23

Application number

SG11201400073SA

Inventor

Christian Dittrich

Gaudenz Danuser

Original Assignee

Harvard College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-23

Filing date

2012-08-23

Publication date

2014-03-28

2012-08-23 Application filed by Harvard College filed Critical Harvard College

2014-03-28 Publication of SG11201400073SA publication Critical patent/SG11201400073SA/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG11201400073SA 2011-08-23 2012-08-23 Peptide nanoparticles and uses thereof SG11201400073SA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161526526P	2011-08-23	2011-08-23
PCT/US2012/052027 WO2013028843A1 (en)	2011-08-23	2012-08-23	Peptide nanoparticles and uses thereof

Publications (1)

Publication Number	Publication Date
SG11201400073SA true SG11201400073SA (en)	2014-03-28

Family

ID=46826904

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201400073SA SG11201400073SA (en)	2011-08-23	2012-08-23	Peptide nanoparticles and uses thereof

Country Status (19)

Country	Link
US (1)	US8828928B2 (en)
EP (1)	EP2748182B1 (en)
JP (1)	JP2014524477A (en)
KR (1)	KR20140068087A (en)
CN (1)	CN104011065B (en)
AU (1)	AU2012298824B2 (en)
BR (1)	BR112014004014A2 (en)
CA (1)	CA2845886A1 (en)
CL (1)	CL2014000418A1 (en)
DK (1)	DK2748182T3 (en)
ES (1)	ES2610779T3 (en)
HU (1)	HUE031511T2 (en)
IL (1)	IL231005A0 (en)
MX (1)	MX2014002062A (en)
PT (1)	PT2748182T (en)
RU (1)	RU2014110901A (en)
SG (1)	SG11201400073SA (en)
WO (1)	WO2013028843A1 (en)
ZA (1)	ZA201401210B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8153435B1 (en)	2005-03-30	2012-04-10	Tracer Detection Technology Corp.	Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US11286489B2 (en) *	2016-02-11	2022-03-29	The Curators Of The University Of Missouri	POSH inhibitor complex biomolecules and amphiphile micelles
EP3432908A4 (en)	2016-03-21	2020-07-29	Rhode Island Council on Postsecondary Education	PH SENSITIVE PEPTIDES
CN109070040B (en) *	2016-12-16	2023-07-28	布里格姆及妇女医院股份有限公司	Systems and methods of protein corona sensor arrays for early detection of disease
CN106832003B (en) *	2017-02-15	2021-01-05	中国药科大学	Acid-sensitive polypeptide and application thereof
CN119185557A (en)	2018-04-06	2024-12-27	阿玛治疗公司	Compositions for controlled release of therapeutic agents
US12319711B2 (en)	2019-09-20	2025-06-03	Northwestern University	Spherical nucleic acids with tailored and active protein coronae
US20220356303A1 (en) *	2021-04-08	2022-11-10	The Curators Of The University Of Missouri	Lipidated poly(amino acid) nanostructures
CN114516819B (en) *	2022-02-25	2024-02-27	顺毅宜昌化工有限公司	Preparation method of N, N' -diacetyl hydrazine
WO2023244536A2 (en) *	2022-06-13	2023-12-21	Neubase Therapeutics, Inc.	Oligonucleotide analogue formulations
CN116004221B (en) *	2022-12-15	2023-12-19	湖南卓润生物科技有限公司	New application of cyclic peptide, acridine labeled complex, preparation method and detection kit

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3270960A (en)	1964-09-11	1966-09-06	Sperry Rand Corp	Fluid sensor
US3773919A (en)	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US3872925A (en)	1973-04-24	1975-03-25	Gearhart Owen Industries	Through-tubing bridge plug
US3842067A (en)	1973-07-27	1974-10-15	American Home Prod	Synthesis of(des-asn5)-srif and intermediates
JPS5726506B2 (en)	1974-03-08	1982-06-04
US4105603A (en)	1977-03-28	1978-08-08	The Salk Institute For Biological Studies	Peptides which effect release of hormones
US4511390A (en)	1983-06-10	1985-04-16	E. I. Du Pont De Nemours And Company	Aralkylcarbamoyl peptide alcohols
US5643873A (en)	1992-05-06	1997-07-01	Affymax Technologies N.V.	Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5625048A (en)	1994-11-10	1997-04-29	The Regents Of The University Of California	Modified green fluorescent proteins
US5654276A (en)	1995-06-07	1997-08-05	Affymax Technologies N.V.	Peptides and compounds that bind to the IL-5 receptor
FR2736642B1 (en)	1995-07-10	1997-09-12	Pasteur Institut	IMMUNOVECTORS, IN PARTICULAR ANTIBODIES AND FRAGMENTS OF ANTIBODIES FOR USE IN THE INTRACELLULAR AND INTRANUCLEAR TRANSPORT OF BIOLOGICALLY ACTIVE PRINCIPLES IN PARTICULAR OF HAPTENES, PROTEINS AND NUCLEIC ACIDS
US6124128A (en)	1996-08-16	2000-09-26	The Regents Of The University Of California	Long wavelength engineered fluorescent proteins
EP1206494B1 (en)	1999-08-02	2004-11-03	Synt:Em S.A.	Computational design methods for making molecular mimetics
EP1372418A4 (en)	2001-02-26	2006-01-25	Univ	Non-oligomerizing tandem fluorescent proteins
US20060084607A1 (en)	2004-07-06	2006-04-20	Lisa Spirio	Purified amphiphilic peptide compositions and uses thereof
CA2713879C (en)	2008-02-01	2020-01-07	Alpha-O Peptides Ag	Self-assembling peptide nanoparticles useful as vaccines
JP2011523353A (en) *	2008-04-28	2011-08-11	プレジデントアンドフェロウズオブハーバードカレッジ	Overcharged protein for cell penetration

2012
- 2012-08-23 DK DK12756593.5T patent/DK2748182T3/en active
- 2012-08-23 MX MX2014002062A patent/MX2014002062A/en unknown
- 2012-08-23 EP EP12756593.5A patent/EP2748182B1/en not_active Not-in-force
- 2012-08-23 HU HUE12756593A patent/HUE031511T2/en unknown
- 2012-08-23 PT PT127565935T patent/PT2748182T/en unknown
- 2012-08-23 BR BR112014004014-1A patent/BR112014004014A2/en not_active IP Right Cessation
- 2012-08-23 CN CN201280052123.9A patent/CN104011065B/en not_active Expired - Fee Related
- 2012-08-23 US US13/592,733 patent/US8828928B2/en not_active Expired - Fee Related
- 2012-08-23 WO PCT/US2012/052027 patent/WO2013028843A1/en active Application Filing
- 2012-08-23 JP JP2014527288A patent/JP2014524477A/en not_active Ceased
- 2012-08-23 CA CA2845886A patent/CA2845886A1/en not_active Abandoned
- 2012-08-23 KR KR1020147007599A patent/KR20140068087A/en not_active Withdrawn
- 2012-08-23 RU RU2014110901/10A patent/RU2014110901A/en not_active Application Discontinuation
- 2012-08-23 ES ES12756593.5T patent/ES2610779T3/en active Active
- 2012-08-23 SG SG11201400073SA patent/SG11201400073SA/en unknown
- 2012-08-23 AU AU2012298824A patent/AU2012298824B2/en not_active Expired - Fee Related
2014
- 2014-02-17 IL IL231005A patent/IL231005A0/en unknown
- 2014-02-18 ZA ZA2014/01210A patent/ZA201401210B/en unknown
- 2014-02-20 CL CL2014000418A patent/CL2014000418A1/en unknown

Also Published As

Publication number	Publication date
CL2014000418A1 (en)	2014-07-25
EP2748182B1 (en)	2016-10-19
PT2748182T (en)	2017-01-20
JP2014524477A (en)	2014-09-22
IL231005A0 (en)	2014-03-31
DK2748182T3 (en)	2017-02-06
US20130064895A1 (en)	2013-03-14
ZA201401210B (en)	2015-12-23
CA2845886A1 (en)	2013-02-28
AU2012298824A1 (en)	2014-03-20
BR112014004014A2 (en)	2020-10-27
WO2013028843A1 (en)	2013-02-28
EP2748182A1 (en)	2014-07-02
HUE031511T2 (en)	2017-07-28
RU2014110901A (en)	2015-09-27
ES2610779T3 (en)	2017-05-03
MX2014002062A (en)	2014-05-28
CN104011065A (en)	2014-08-27
KR20140068087A (en)	2014-06-05
AU2012298824B2 (en)	2017-06-01
US8828928B2 (en)	2014-09-09
NZ622045A (en)	2016-02-26
CN104011065B (en)	2017-06-30

Publication	Publication Date	Title
IL288203B (en)	2022-10-01	Meditopes and meditope-binding antibodies and uses thereof
IL259436A (en)	2018-07-31	Anti-angptl3 antibodies and uses thereof
IL266880B (en)	2022-04-01	Peptide conjugated particles
IL233051A0 (en)	2014-07-31	Anti-phf-tau-antibodies and their uses
PL2691443T3 (en)	2021-08-30	Conjugated lipomers and uses thereof
IL232399A0 (en)	2014-06-30	Anti-fgfr2 antibodies and uses thereof
IL229844B (en)	2022-02-01	Anti-psgl-1-antibodies and uses thereof
ZA201401210B (en)	2015-12-23	Peptide nanoparticles and uses thereof
SG11201500111VA (en)	2015-03-30	Peptides and uses thereof
GB201110783D0 (en)	2011-08-10	Methods and uses
SG10201701828WA (en)	2017-04-27	Peptides and their uses
GB201116774D0 (en)	2011-11-09	Uses and methods
EP2825548A4 (en)	2016-02-24	Modified kisspeptin peptides and uses thereof
SG11201402139UA (en)	2014-06-27	High mast2-affinity polypeptides and uses thereof
PL2627668T3 (en)	2017-08-31	Peptides and uses
EP2716359A4 (en)	2014-04-23	Complex and uses thereof
GB201106357D0 (en)	2011-06-01	Composition and uses thereof
PT2790739T (en)	2019-02-04	Nanoparticles and uses thereof
EP2762149A4 (en)	2015-06-03	Erythropoietin-derived peptide and use therefor
EP2776064A4 (en)	2015-08-05	Provasopressin antagonists and uses thereof
GB201108490D0 (en)	2011-07-06	Methods and uses
GB201214769D0 (en)	2012-10-03	Methodsa and peptides